NapseflowNapseflow
Recherche

The Medicines Patent Pool is improving access to essential medication where it’s most needed, but does it make economic sense?

The Conversation France · mis à jour 17 août

A new UN-backed initiative is enabling qualified generic manufacturers to develop, produce and supply vital medicines such as antivirals independently. By reducing the cost of essential medicines, pooled licensing particularly benefits low- and middle-income countries, in sub-Saharan Africa, for instance.

Sujets complémentaires

Ce contenu a été généré par intelligence artificielle à partir de l'article source. Il peut contenir des erreurs ou imprécisions.